Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Other Operating Expenses (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Other Operating Expenses for 6 consecutive years, with $382113.0 as the latest value for Q4 2021.

  • Quarterly Other Operating Expenses rose 98.58% to $382113.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2021, up 84.81% year-over-year, with the annual reading at $189470.0 for FY2025, 66.82% down from the prior year.
  • Other Operating Expenses for Q4 2021 was $382113.0 at ENDRA Life Sciences, up from $275565.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $382113.0 in Q4 2021, with the low at $1124.0 in Q1 2017.
  • Average Other Operating Expenses over 5 years is $137124.4, with a median of $111066.0 recorded in 2018.
  • The sharpest move saw Other Operating Expenses skyrocketed 9435.32% in 2018, then plummeted 72.14% in 2019.
  • Over 5 years, Other Operating Expenses stood at $67201.0 in 2017, then tumbled by 37.61% to $41928.0 in 2018, then surged by 298.47% to $167070.0 in 2019, then increased by 15.18% to $192424.0 in 2020, then surged by 98.58% to $382113.0 in 2021.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $382113.0, $275565.0, and $256763.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.